Tsuji Eiichi, Hiki Naoki, Nomura Sachiyo, Fukushima Ryoji, Kojima Jun-ichi, Ogawa Toshihisa, Mafune Ken-ichi, Mimura Yoshikazu, Kaminishi Michio
Department of Surgery, University of Tokyo, Tokyo, Japan.
Int J Cancer. 2003 Nov 1;107(2):303-8. doi: 10.1002/ijc.11196.
Chemotherapy is 1 method for the treatment of cancer, but serious side effects can sometimes limit the dosage given. Mild fever and diarrhea are common side effects of cancer chemotherapy. Gastrointestinal injury induced by chemotherapeutic agents may result in bacterial/endotoxin translocation from the gut into the systemic circulation. An experimental study was therefore conducted to clarify the effect of systemic chemotherapeutic agents on gastrointestinal barrier function. Male Wistar rats were divided into a 5-fluorouracil (5-FU) group (100 mg/kg/day for 4 days; n = 27) and a control group (n = 5). All rats were fasted and central venous catheterization was performed for total parenteral nutrition and blood sampling. Intestinal tissue was also sampled for pathological examination. Plasma levels of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFalpha) were determined by ELISA, bacterial translocation was quantified by lymph node culture and plasma endotoxin content of portal blood was measured by the Limulus-amebocyte-lysate test. In the 5-FU group on day 4, a proportion of rats exhibited severe watery diarrhea (73.9%) and occasional vomiting (86.2%). The levels of plasma TNFalpha and IL-6 were seen to increase, peaking at day 6 (IL-6, 350.0 +/- 67.8 pg/ml; TNFalpha, 26.1 +/- 3.2 pg/ml). The pathological findings also changed on day 4. On day 6, 90% of the rats in the 5-FU group showed dramatic sepsis-like manifestations, whereas the control group did not. Within the 5-FU group, only at day 6 was bacterial translocation in the rat mesenteric lymph nodes or significantly elevated levels of endotoxin evident. These results suggest that bacterial/endotoxin translocation might cause sepsis-like manifestations after systemic chemotherapy.
化疗是治疗癌症的一种方法,但严重的副作用有时会限制给药剂量。轻度发热和腹泻是癌症化疗常见的副作用。化疗药物引起的胃肠道损伤可能导致细菌/内毒素从肠道转移至体循环。因此,进行了一项实验研究以阐明全身化疗药物对胃肠道屏障功能的影响。将雄性Wistar大鼠分为5-氟尿嘧啶(5-FU)组(100mg/kg/天,共4天;n = 27)和对照组(n = 5)。所有大鼠禁食,并进行中心静脉置管以便进行全胃肠外营养和采血。还采集肠道组织进行病理检查。通过酶联免疫吸附测定法测定血浆白细胞介素-6(IL-6)和肿瘤坏死因子α(TNFα)水平,通过淋巴结培养对细菌移位进行定量,并通过鲎试剂法测定门静脉血的血浆内毒素含量。在第4天,5-FU组的一部分大鼠出现严重水样腹泻(73.9%)和偶尔呕吐(86.2%)。血浆TNFα和IL-6水平升高,在第6天达到峰值(IL-6,350.0 +/- 67.8 pg/ml;TNFα,26.1 +/- 3.2 pg/ml)。病理结果在第4天也发生了变化。在第6天,5-FU组90%的大鼠出现明显的败血症样表现,而对照组则没有。在5-FU组内,仅在第6天大鼠肠系膜淋巴结中出现细菌移位或内毒素水平显著升高。这些结果表明,细菌/内毒素移位可能在全身化疗后引起败血症样表现。